-

12:59:36 AM

CDNA Stock News

CDNA - Caredx Inc

04/22/21 11:37 AM

Nasdaq : CDNA

Palmetto MolDx Issues Foundational Coverage for Molecular Testing in Solid Organ Allograft Rejection

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of

RHEA-AI

neutral

04/22/21 7:00 AM

Nasdaq : CDNA

CareDx to Debut Multicenter Data on AlloSure® Lung, an Analytically and Clinically Validated Biomarker of Graft Injury for Lung Transplant Patients

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,

RHEA-AI

neutral

04/21/21 4:00 PM

Nasdaq : CDNA

conferencesearnings

CareDx to Report First Quarter 2021 Financial Results

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,

RHEA-AI

neutral

04/20/21 7:00 AM

Nasdaq : CDNA

CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically

RHEA-AI

positive

04/16/21 7:00 AM

Nasdaq : CDNA

conferences

CareDx to Present at UNOS Transplant Management Forum

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization

RHEA-AI

neutral

04/08/21 7:00 AM

Nasdaq : CDNA

CareDx Announces New HLA Typing Service Offering for Research Purposes

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value

RHEA-AI

neutral

04/05/21 7:00 AM

Nasdaq : CDNA

conferences

CareDx to Participate in National Kidney Foundation 2021 Spring Clinical Meetings

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically

RHEA-AI

neutral

03/31/21 7:00 AM

Nasdaq : CDNA

management

CareDx Enhances Leadership Team with Key Appointments

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare

RHEA-AI

very positive

03/23/21 7:00 AM

Nasdaq : CDNA

clinical trial

CareDx Supports Vir Biotechnology’s Clinical Trial Recruitment Efforts for COMET-ICE

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,

RHEA-AI

neutral

03/17/21 7:00 AM

Nasdaq : CDNA

acquisition

CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers,

RHEA-AI

neutral

Prev 4 5 6 7 8 9 10 11 12 13 Next

CDNA Data

IndustryMedical Laboratories
Websitewww.caredx.com
CeoPeter Maag
Security nameCaredx Inc
Issue typecs
SectorHealth Care and Social Assistance
Sic code8071
Employees466
Tags
- Health Technology
- Medical Specialties
- Health Care and Social Assistance
- Medical Laboratories
Address1 Tower Place
Address29Th Floor
StateCalifornia
CitySouth San Francisco
Zip94080
CountryUS
Phone14152872300

About Caredx Inc

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.